Product

EPAX® NovusLipid

EPA and DHA are well-known for their proven benefits to human health — but they’re only part of the story.

Female scientist in lab coat and safety glasses handling a conical flask with liquid under a lab funnel.

Epax® NovusLipid is our new product line, the next generation of marine lipids, exploring fatty acids beyond traditional Omega-3s.

EPAX® Evolve 05

The world’s first commercially available VLC-PUFA

EPAX® Evolve 05 is a marine omega-3 concentrated oil containing very long chain polyunsaturated fatty acids (VLC-PUFAs) - a new frontier in lipid science.

Developed with proprietary Epax® technology, it delivers a concentrated source of these rare fatty acids, which play essential roles in physiological functions throughout the body.

The role of ELOVL2

ELOVL2 is a key enzyme responsible for producing very long chain fatty acids (VLCFAs), which are essential for healthy cellular function throughout the body.

The impact of aging

As we age, ELOVL2 activity naturally declines, leading to reduced VLCFA levels and contributing to the biological processes of aging.

Restoring vital VLCFAs

EPAX® Evolve 05 is designed to help counter this decline by replenishing important VLCFAs, supporting healthy aging and optimal physiological function.

EPAX® Omega 3-9-11

The Omega dream team

The cold, clean waters of the North Atlantic produce fish uniquely rich in both Omega-3 PUFAs (EPA & DHA) and long-chain monounsaturated fatty acids (LC-MUFAs) — Omegas 9 and 11.

High‑potency composition

Concentrates EPA/DHA + LC‑MUFAs (cetoleic, gondoic) to ≥720 mg/g via Epax® EQP+ Tech, maximizing active load per dose

Clinically supported skin health

Randomized, double‑blind pilot with cetoleic‑rich oil significantly reduced facial redness; aligns with LC‑MUFA anti‑inflammatory mechanism.

Metabolic synergy

LC‑MUFAs with EPA/DHA show complementary effects; preclinical models improved blood lipids, insulin sensitivity and glucose vs single‑lipid oils.

Product list: Epax® NovusLipid

The latest in marine fatty acid innovation

Our facility is cGMP compliant, US FDA-inspected for manufacture of Pharmaceutical Ingredients, and approved by the Norwegian Medical Products Agency for manufacture of APIs. All our products meet, or exceed, known purity regulatory standards. We also use IP-certified antioxidant solutions to guarantee 100% GMO-free products.

EPAX® Evolve 05
EPA mg/g min. values
-
DHA mg/g min. values
-
CETOLEIC mg/g min. values
-
GONDOIC mg/g min. values
-
VLC-PUFA  mg/g min. values
50
OMEGA-3 mg/g min. values
400
EPAX® Omega 3-9-11
EPA mg/g min. values
50
DHA mg/g min. values
200
CETOLEIC mg/g min. values
300
GONDOIC mg/g min. values
90
VLC-PUFA  mg/g min. values
-
OMEGA-3 mg/g min. values
300

Beyond Omega-3: Redefining Marine Lipids

Child in a yellow jacket viewing large fish swimming underwater in an the Aalesund aquarium.
Condition-specific

EPAX Evolve 05 and VLC-PUFAs

VLC-FAs and VLC-PUFAs science is very promising, and we are very excited to see what the future may hold!

Eye Health

Supporting retinal function and visual performance

Healthy lifespan

Aiding development and cognitive protection

Reproductive health

Supporting structural integrity and strength

Condition-specific

EPAX Omega 3-9-11 and LC-MUFAs

LC-MUFAs are already extensively studied, and more data is on its way.

Skin health

Supporting retinal function and visual performance

Metabolic health

Aiding development and cognitive protection

Healthy inflammatory response

Supporting structural integrity and strength